Literature DB >> 20869297

Spectroscopic studies of the interaction of aspirin and its important metabolite, salicylate ion, with DNA, A·T and G·C rich sequences.

S Z Bathaie1, L Nikfarjam, R Rahmanpour, A A Moosavi-Movahedi.   

Abstract

Among different biological effects of acetylsalicylic acid (ASA), its anticancer property is controversial. Since ASA hydrolyzes rapidly to salicylic acid (SA), especially in the blood, interaction of both ASA and SA (as the small molecules) with ctDNA, oligo(dA·dT)15 and oligo(dG·dC)15, as a possible mechanism of their action, is investigated here. The results show that the rate of ASA hydrolysis in the absence and presence of ctDNA is similar. The spectrophotometric results indicate that both ASA and SA cooperatively bind to ctDNA. The binding constants (K) are (1.7±0.7)×10(3) M(-1) and (6.7±0.2)×10(3) M(-1) for ASA and SA, respectively. Both ligands quench the fluorescence emission of ethidium bromide (Et)-ctDNA complex. The Scatchard plots indicate the non-displacement based quenching (non-intercalative binding). The circular dichroism (CD) spectra of ASA- or SA-ctDsNA complexes show the minor distortion of ctDNA structure, with no characteristic peaks for intercalation of ligands. Tm of ctDNA is decreased up to 3°C upon ASA binding. The CD results also indicate more distortions on oligo(dG·dC)15 structure due to the binding of both ASA and SA in comparison with oligo(dA·dT)15. All data indicate the more affinity for SA binding with DNA minor groove in comparison with ASA which has more hydrophobic character.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869297     DOI: 10.1016/j.saa.2010.08.078

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  4 in total

1.  The protein kinase promiscuities in the cancer-preventive mechanisms of NSAIDs.

Authors:  Povilas Norvaisas; Diana Chan; Kenji Yokoi; Bhuvanesh Dave; Arturas Ziemys
Journal:  Eur J Cancer Prev       Date:  2016-01       Impact factor: 2.497

2.  Molecular Mechanism of Binding between 17β-Estradiol and DNA.

Authors:  Tamsyn A Hilder; Justin M Hodgkiss
Journal:  Comput Struct Biotechnol J       Date:  2016-12-12       Impact factor: 7.271

3.  DNA-binding studies of valrubicin as a chemotherapy drug using spectroscopy and electrochemical techniques.

Authors:  Reza Hajian; Parvin Hossaini; Zahra Mehrayin; Pei Meng Woi; Nafiseh Shams
Journal:  J Pharm Anal       Date:  2017-01-11

4.  2,4-Dichlorophenoxyacetic Thiosemicarbazides as a New Class of Compounds Against Stomach Cancer Potentially Intercalating with DNA.

Authors:  Monika Pitucha; Agnieszka Korga-Plewko; Pawel Kozyra; Magdalena Iwan; Agnieszka A Kaczor
Journal:  Biomolecules       Date:  2020-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.